Shares of NeoProbe (NEOP) jump in post-trading after the FDA agrees to review its new-drug...
Shares of NeoProbe (NEOP) jump in post-trading after the FDA agrees to review its new-drug application for its cancer-detection agent Lymphoseek. Shares +16% AH.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs